Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 60473-60474 [2014-23857]
Download as PDF
<![CDATA[
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2015.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters for Discussion: The agenda for
the Advisory Board meeting includes:
NIOSH Program Update; Department of
Labor Program Update; Department of
Energy Program Update; SEC Issues
Work Group Report on ‘‘Sufficient
Accuracy’’/Co-Worker Dose Modeling;
SEC Petitions Update; an update on SEC
and Site Profile work for the Area IV of
the Santa Susana Field Laboratory
(Ventura County, CA); and Board Work
Session.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted to the contact person below
well in advance of the meeting. Any
written comments received will be
provided at the meeting in accordance
with the redaction policy provided
below.
Policy on Redaction of Board Meeting
Transcripts (Public Comment): (1) If a
person making a comment gives his or
her personal information, no attempt
will be made to redact the name;
however, NIOSH will redact other
personally identifiable information,
such as contact information, social
security numbers, case numbers, etc., of
the commenter.
(2) If an individual in making a
statement reveals personal information
(e.g., medical or employment
VerDate Sep<11>2014
17:15 Oct 06, 2014
Jkt 235001
information) about themselves that
information will not usually be
redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator
will, however, review such revelations
in accordance with the Federal
Advisory Committee Act and if deemed
appropriate, will redact such
information.
(3) If a commenter reveals personal
information concerning a living third
party, that information will be reviewed
by the NIOSH FOIA coordinator, and
upon determination, if deemed
appropriated, such information will be
redacted, unless the disclosure is made
by the third party’s authorized
representative under the Energy
Employees Occupational Illness
Compensation Program Act (EEOICPA)
program.
(4) In general, information concerning
a deceased third party may be disclosed;
however, such information will be
redacted if (a) the disclosure is made by
an individual other than the survivor
claimant, a parent, spouse, or child, or
the authorized representative of the
deceased third party; (b) if it is unclear
whether the third party is living or
deceased; or (c) the information is
unrelated or irrelevant to the purpose of
the disclosure.
The Board will take reasonable steps
to ensure that individuals making
public comment are aware of the fact
that their comments (including their
name, if provided) will appear in a
transcript of the meeting posted on a
public Web site. Such reasonable steps
include: (a) A statement read at the start
of each public comment period stating
that transcripts will be posted and
names of speakers will not be redacted;
(b) A printed copy of the statement
mentioned in (a) above will be
displayed on the table where
individuals sign up to make public
comments; (c) A statement such as
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings.
Contact Person for More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road
NE., MS E–20, Atlanta, Georgia 30333,
telephone: (513) 533–6800, toll free: 1–
800–CDC–INFO, email: dcas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for the Centers
for Disease Control and Prevention and
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
60473
the Agency for Toxic Substances and
Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–23855 Filed 10–6–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Date and Time: October 29, 2014, EST,
10:30 a.m.–5:00 p.m.
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public, but without a
public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact person
below. Written comments received in
advance of the meeting will be included in
the official record of the meeting. The public
is also welcome to listen to the meeting by
joining the teleconference at the USA tollfree, dial-in number, 1–866–659–0537 and
the passcode is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction, which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
E:\FR\FM\07OCN1.SGM
07OCN1
60474
Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices
asabaliauskas on DSK5VPTVN1PROD with NOTICES
2001, renewed at appropriate intervals, and
will expire on August 3, 2015.
Purpose: The Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee for Dose
Reconstruction Reviews was established to
aid the Advisory Board in carrying out its
duty to advise the Secretary, HHS, on dose
reconstruction.
Matters for Discussion: The agenda for the
Subcommittee meeting includes the
following dose reconstruction program
quality management and assurance activities:
Discussion of current findings from NIOSH
and Advisory Board dose reconstruction
blind reviews; discussion of dose
reconstruction cases under review (cases
involving Hanford, Mound Plant, Y–12, Oak
Ridge National Laboratory, Lawrence
Livermore National Laboratory, Pacific
Proving Grounds, Hooker Electrochemical,
Simonds Saw and Steel, Bethlehem Steel,
Weldon Spring, W.R. Grace, Westinghouse,
International Minerals and Chemical (IMC)
Corporation, Koppers Company, Bridgeport
Brass, Uranium Mill in Monticello, General
Steel Industries, and DuPont Deepwater
Works); and preparation of the Advisory
Board’s next report to the Secretary, HHS,
summarizing the results of completed dose
reconstruction reviews.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road
NE., Mailstop E–20, Atlanta GA 30333,
Telephone (513)533–6800, Toll Free
1(800)CDC–INFO, Email ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–23857 Filed 10–6–14; 8:45 am]
BILLING CODE 4163–19–P
VerDate Sep<11>2014
17:15 Oct 06, 2014
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee.
[FR Doc. 2014–23856 Filed 10–6–14; 8:45 am]
Times and Dates:
8:00 a.m.–5:45 p.m., EDT, October 29, 2014
8:00 a.m.–1:15 p.m., EDT, October 30, 2014
Place: Centers for Disease Control and
Prevention, Tom Harkin Global
Communications Center, 1600 Clifton Road
NE., Building 19, Kent ‘‘Oz’’ Nelson
Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Director, CDC, on the
appropriate use of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines. Further, under
provisions of the Affordable Care Act, at
section 2713 of the Public Health Service
Act, immunization recommendations of the
ACIP that have been adopted by the Director
of the Centers for Disease Control and
Prevention must be covered by applicable
health plans.
Matters for Discussion: The agenda will
include discussions on: General
recommendations; human papillomavirus
vaccines; influenza; novel influenza
vaccines, tetanus, diphtheria, and acellular
pertussis vaccine (Tdap); meningococcal
vaccines; child/adolescent immunization
schedule; adult immunization schedule;
immunization safety; hepatitis vaccines;
typhoid vaccines; and vaccine supply.
Recommendation votes are scheduled for
general recommendations, child/adolescent
immunization schedule, adult immunization
schedule and typhoid vaccines. Time will be
available for public comment.
Agenda items are subject to change as
priorities dictate. Contact Person for More
Information: Stephanie Thomas, National
Center for Immunization and Respiratory
Diseases, CDC, 1600 Clifton Road NE., MS–
A27, Atlanta, Georgia 30333, telephone 404/
639–8836; Email ACIP@CDC.GOV
Meeting is Webcast live via the World
Wide Web; for instructions and more
information on ACIP please visit the ACIP
Web site: https://www.cdc.gov/vaccines/acip/
index.html.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
Food and Drug Administration
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Docket No. FDA–2014–N–0386]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Orphan Drugs;
Common European Medicines Agency/
Food and Drug Administration
Application Form for Orphan Medicinal
Product Designation
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995
(PRA).
SUMMARY:
Fax written comments on the
collection of information by November
6, 2014.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0167. Also
include the FDA docket number found
in brackets in the heading of this
document.
DATES:
FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\07OCN1.SGM
07OCN1
]]>Agencies
[Federal Register Volume 79, Number 194 (Tuesday, October 7, 2014)]
[Notices]
[Pages 60473-60474]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23857]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH or the Advisory Board),
National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the
aforementioned subcommittee:
Date and Time: October 29, 2014, EST, 10:30 a.m.-5:00 p.m.
Place: Audio Conference Call via FTS Conferencing.
Status: Open to the public, but without a public comment period.
The public is welcome to submit written comments in advance of the
meeting, to the contact person below. Written comments received in
advance of the meeting will be included in the official record of
the meeting. The public is also welcome to listen to the meeting by
joining the teleconference at the USA toll-free, dial-in number, 1-
866-659-0537 and the passcode is 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing
advice on the development of probability of causation guidelines
that have been promulgated by the Department of Health and Human
Services (HHS) as a final rule; advice on methods of dose
reconstruction, which have also been promulgated by HHS as a final
rule; advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program; and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3,
[[Page 60474]]
2001, renewed at appropriate intervals, and will expire on August 3,
2015.
Purpose: The Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class. The Subcommittee for Dose Reconstruction Reviews was
established to aid the Advisory Board in carrying out its duty to
advise the Secretary, HHS, on dose reconstruction.
Matters for Discussion: The agenda for the Subcommittee meeting
includes the following dose reconstruction program quality
management and assurance activities: Discussion of current findings
from NIOSH and Advisory Board dose reconstruction blind reviews;
discussion of dose reconstruction cases under review (cases
involving Hanford, Mound Plant, Y-12, Oak Ridge National Laboratory,
Lawrence Livermore National Laboratory, Pacific Proving Grounds,
Hooker Electrochemical, Simonds Saw and Steel, Bethlehem Steel,
Weldon Spring, W.R. Grace, Westinghouse, International Minerals and
Chemical (IMC) Corporation, Koppers Company, Bridgeport Brass,
Uranium Mill in Monticello, General Steel Industries, and DuPont
Deepwater Works); and preparation of the Advisory Board's next
report to the Secretary, HHS, summarizing the results of completed
dose reconstruction reviews.
The agenda is subject to change as priorities dictate.
Contact Person for More Information: Theodore Katz, Designated
Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E-20,
Atlanta GA 30333, Telephone (513)533-6800, Toll Free 1(800)CDC-INFO,
Email ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2014-23857 Filed 10-6-14; 8:45 am]
BILLING CODE 4163-19-P
